ArticlemBio2024
Differentiation of hypervirulent and classical
Abstract read
In one paragraph
Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.
0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
104 citing papers in PubMed.
- Comparative genomics of hypervirulent Klebsiella pneumoniae isolates from Brazil.Archives of microbiology · 2026Article
- Klebsiella pneumoniae from community-acquired infections and an urban river share antimicrobial resistance profiles and high-risk lineages but differ in virulence.Archives of microbiology · 2026Article
- Phenotypic screening of hypervirulentMicrobiology spectrum · 2026Article
- HypervirulentOpen forum infectious diseases · 2026Article
- Genomic characterization of CTX-M-15-producing Klebsiella pneumoniae ST709-KL9 from neonatal bacteraemia in eastern India.Molecular biology reports · 2026Article
- Genetic characterization of blaNDM-1-positive Klebsiella quasipneumoniae subsp. similipneumoniae from a human carrier.European journal of microbiology & immunology · 2026Article
- Emerging hypervirulentInfectious medicine · 2026Review
- Article
- Tet-ON and Tet-OFF regulation in hypervirulentMicrobiology spectrum · 2026Article
- Genomic, virulent and phenotypic characterization of a cerebrospinal fluid-derived ST86-KL2 hypervirulent Klebsiella pneumoniae isolate from a patient with meningitis and diabetes mellitus.BMC microbiology · 2026Article
- Distinct and shared impacts of virulence plasmids on the phenotype and transcriptome in convergent carbapenem-resistant and hypervirulentMicrobiology spectrum · 2026Article
- Comparative analysis of virulence factors and two-component systems expression in carbapenem-resistant and carbapenem-susceptibleMicrobiology spectrum · 2026Article
- Clinical and Genomic Characterization of High-Risk Multidrug-ResistantMicroorganisms · 2026Article
- Genomics of Hospital-Associated Brazilian Multidrug-Resistant Klebsiella pneumoniae: Abundance of Resistance and Virulence Genes and Mosaicism of the blaCurrent microbiology · 2026Article
- Genomic Characterisation of Antimicrobial Resistance and Virulence of Animal-DerivedAntibiotics (Basel, Switzerland) · 2026Article
- Clinical and genomic characteristics of hypervirulent Klebsiella pneumoniae isolated from throat culture suggesting an emerging causative agent of pharyngitis.BMC infectious diseases · 2026Article
- Genomic analysis of virulence and antimicrobial resistance in Klebsiella isolates from farmed sika deer.BMC genomics · 2026Article
- Effective macrophage clearance ofbioRxiv : the preprint server for biology · 2026Article
- Two case reports on the identification and management of hypervirulentASM case reports · 2026Article
- Detection of hypervirulence genes in carbapenem resistant Klebsiella pneumoniae from cancer patients at a tertiary referral hospital in Nepal.BMC infectious diseases · 2026Article
44 more citing papers are in PubMed but not listed here.
Corrections and comments
- Update of
Authors and funding
14 authors.
Thomas A RussoVeterans Administration Western New York Healthcare System, University at Buffalo, Buffalo, New York, USA.ORCID 0000-0003-4566-7442
Cassandra L AlvaradoVeterans Administration Western New York Healthcare System, University at Buffalo, Buffalo, New York, USA.
Connor J DaviesVeterans Administration Western New York Healthcare System, University at Buffalo, Buffalo, New York, USA.
Zachary J DrayerDepartment of Medicine, University at Buffalo, Buffalo, New York, USA.
Ulrike Carlino-MacDonaldVeterans Administration Western New York Healthcare System, University at Buffalo, Buffalo, New York, USA.
Alan HutsonDepartment of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Ting L LuoMultidrug-Resistant Organism Repository and Surveillance Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Melissa J MartinMultidrug-Resistant Organism Repository and Surveillance Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Brendan W CoreyMultidrug-Resistant Organism Repository and Surveillance Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Kara A MoserDivision of Healthcare Quality Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
J Kamile RasheedDivision of Healthcare Quality Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Alison L HalpinDivision of Healthcare Quality Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0003-1643-1617
Patrick T McGannMultidrug-Resistant Organism Repository and Surveillance Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.ORCID 0000-0003-1548-9438
Francois LebretonMultidrug-Resistant Organism Repository and Surveillance Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.ORCID 0000-0002-7157-5026
Funding
Development of a diagnostic test for hypervirulent Klebsiella pneumoniaeR21AI123558 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI RUSSO, THOMAS A · 2016 to 2017
$439kIdentification of new or unrecognized virulence genes in hypervirulent Klebsiella pneumoniae and antivirulence genes in classical K. pneumoniae.R21AI141826 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI RUSSO, THOMAS A · 2020 to 2021
$432kDetermining the value of PBP 7/8 as an antimicrobial target for XDR-A. baumannniiI01BX004677 · VA · VA WESTERN NEW YORK HEALTHCARE SYSTEM · PI THOMAS A RUSSO · 2020 to 2026
–BLRD VA I01 BX004677NIAID NIH HHS R21 AI123558NIAID NIH HHS R21 AI141826
Abstract
Distinguishing hypervirulent (hvKp) from classical
Indexed as
Klebsiella InfectionsKlebsiella pneumoniaeAnimalsAnti-Bacterial AgentsBiomarkersHumansMiceSiderophoresAnti-Bacterial AgentsBiomarkersSiderophoresbiomarkerclassicaldiagnosishypervirulentKlebsiella
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.